Adaptin Bio (APTN) Long-Term Deferred Tax (2022 - 2024)

Adaptin Bio (APTN) has 3 years of Long-Term Deferred Tax data on file, last reported at $193876.0 in Q4 2024.

• For the quarter ending Q4 2024, Long-Term Deferred Tax rose 138.37% year-over-year to $193876.0; the trailing twelve-month figure through Dec 2024 stood at $193876.0 (up 138.37% YoY), and the FY2024 full-year result was $193876.0, up 138.37% from the prior year.
• Long-Term Deferred Tax rose to $193876.0 in Q4 2024, from $81335.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $193876.0 in Q4 2024 to a low of $27804.0 in Q4 2022.
• A 3-year average of $101005.0 and a median of $81335.0 in 2023 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax surged 192.53% in 2023 and jumped 138.37% in 2024, its largest moves.
• Tracing APTN's Long-Term Deferred Tax over 3 years: stood at $27804.0 in 2022, then surged by 192.53% to $81335.0 in 2023, then jumped by 138.37% to $193876.0 in 2024.
• Business Quant data shows APTN's Long-Term Deferred Tax at $193876.0 in Q4 2024, $81335.0 in Q4 2023, and $27804.0 in Q4 2022.